Tracking the distribution of stem cells is crucial to their therapeutic use. However, the usage of current vectors in cellular labeling is restricted by their low internalizing efficiency. Here, we reported a cellular labeling approach with a novel vector composed of mesoporous silica nanoparticles (MSNs) conjugated with fluorescein isothiocyanate in human bone marrow mesenchymal stem cells and 3T3-L1 cells, and the mechanism about fluorescein isothiocyanate-conjugated MSNs (FITC-MSNs) internalization was studied. FITC-MSNs were efficiently internalized into mesenchymal stem cells and 3T3-L1 cells even in short-term incubation. The process displayed a time-and concentration-dependent manner and was dependent on clathrin-mediated endocytosis. In addition, clathrin-dependent endocytosis seemed to play a decisive role on more internalization and longer stay of FITC-MSNs in mesenchymal stem cells than in 3T3-L1 cells. The internalization of FITC-MSNs did not affect the cell viability, proliferation, immunophenotype, and differentiation potential of mesenchymal stem cells, and 3T3-L1 cells. Finally, FITC-MSNs could escape from endolysosomal vesicles and were retained the architectonic integrity after internalization. We conclude that the advantages of biocompatibility, durability, and higher efficiency in internalization suit MSNs to be a better vector for stem cell tracking than others currently used.
anotechnology is currently undergoing explosive development on many fronts. Especially in the biomedical field, the technology plays an innovative role in various applications, including imaging, drug delivery, biomarkers, and biosensers (1-3). Significant efforts have been devoted to developing new nanoparticles, as they are expected to offer great opportunities for successful biomedical applications. For example, numerous reports about cell imaging using nanoparticles such as semiconductor nanocrystals (quantum dots) (4) and superparamagnetic iron oxide nanoparticles (5-7) have been reported.
In the past decade, the therapeutic use of stem cells in replacing damaged endogenous cell populations has received plentiful consideration. To distinguish whether cellular regeneration originated from exogenous cell source, the development of techniques to noninvasively trace therapeutic stem cells in patients is crucial. Among the different methods, the use of superparamagnetic nanoparticles coated with a polymer shell as magnetic resonance imaging (MRI) contrast agents is reported to be used to track transplanted stem cells (8) (9) (10) (11) (12) (13) (14) (15) . To track stem cells by MRI, stem cells must be labeled magnetically either by endocytic internalizing (14) (15) (16) or cell surface attachment of magnetic nanoparticles (17) . However, cellular tracking by these polymer-coated nanoparticles has some serious limitations, including their toxicity to cells and low efficiency in cellular internalizing.
On the other hand, a number of nanoparticles attached with protein transduction domains (PTDs) are capable of producing high levels of cell internalization and are therefore useful for cell tracking (7, 8, 14) . PTDs also promote the delivery of peptides and proteins into cells (18) , which indicates an efficient drug delivery. However, there are a number of limitations for these PTD vectors. First, all of them require preconjugation to the surfaces of nanoparticles for cell tracking (8) . Second, their ability in drug delivery is constrained because these nanoparticles can only carry peptide or protein therapeutics, and cross-linking to the target peptide or protein is needed (19) . Thus, it would be highly desirable to develop a nanoparticle carrier that is nontoxic, biocompatible, and highly efficient in cell internalization. The nanoparticles also should have the ability to carry or deliver multiple agents for cell tracking or therapeutic purpose.
Mesoporous materials, especially MCM-type, possess many characteristics such as ordered pore architecture, high surface area, large pore volume, well-defined and tunable pore size. These unique features make them suitable reservoirs for drugs and other biomolecules. A key issue in the utility of these mesoporous materials is minimizing the material size to a nanometer. Recently, in the case of the hexagonal phase MCM-41 at the nanoscale, the drug adsorbing and releasing behavior has been explored using ibuprofen as a model drug (20) (21) (22) . However, these mesoporous nanoparticles are rarely applied in cell tracking before. In the present study, we demonstrated the efficient cellular internalization of fluorescein isothiocyanate-conjugated mesoporous silica nanoparticles (FITC-MSNs) with highly ordered hexagonal pores and well-defined hexagonal edges and further investigated the mechanisms of cellular uptake of FITC-MSNs in 3T3-L1 cells and human mesenchymal stem cells (hMSCs). We also examined the behavior and the biofunctional effects of FITC-MSNs on hMSCs to evaluate their possibility for being cell trackers. 
MATERIALS AND METHODS

FITC-MSN formulation and characterization
FITC-MSNs with well-ordered hexagonal pore structure were synthesized under diluted tetraethoxy orthosilicate (TEOS) and low surfactant conditions with NH 4 OH as a catalyst in a specially designed two-step preparation. The dye-functionalized mesoporous silica nanoparticles were prepared by cocondensation. First, N-1-(3-trimethoxysilylpropyl)-N'-fluoresceyl thiourea (FITC-APTMS) was formed by stirring fluorescein isothiocyanate (FITC) in ethanolic 3-aminopropyltrimethoxysilane (APTMS) solution (the amount of APTMS was 9 mol% of TEOS and represented a larger proportion of the solution than FITC) in the dark for 24 h. Separately, cetyltrimethylammonium bromide (CTMAB) was dissolved in 0.5 M NH 4 OH (pH 11.3) at 50°C, and 0.2 M dilute TEOS (in ethanol) was added with stirring. The stirring was continued for 5 h, then FITC-APTMS was added and more dilute ethanolic TEOS was added with vigorous stirring for 1 h. The solution was then aged at 50°C for 24 h. The final pH of the nanoparticle suspension decreased to 9. The molar ratio of the reaction mixture was 3000 (H 2 O): 28.35 (NH 3 ): 27.55 (C 2 H 5 OH): 1.00 (TEOS): 0.31 (CTMAB). Samples were collected by centrifuge at 12,000 rpm for 20 min and then washed and redispersed with deionized water and ethanol several times. The solid products were obtained by centrifuge and dried at 60°C overnight. The surfactant templates were removed by extraction in acidic ethanol (1 g HCl/ 50 ml ethanol). By separating the nuclei formation and particle growth into two steps in dilute alkaline solution, well-dispersed nanoparticles were formed. The yield of the hexagonal shape was high, and the size was quite uniform. The morphology and structure of FITC-MSNs were examined by the transmission electron microscope (TEM; JEOL-JSM-1200EX II operating at an acceleration voltage of 80 kV). The TEM images showed that FITC-MSNs had well-defined hexagonal edges and were uniform in size ~110 nm (Fig. 1A) . Highly ordered porous in the individual FITC-MSN were shown in Fig.  1B .
Cell culture
hMSCs were isolated from bone marrow of normal donors. The bone marrow aspirate was added to low-glucose Dulbecco's modified Eagle's medium (DMEM; Gibco) containing 25 U/ml heparin in 1:1 ratio, fractionated by Ficoll-Paque density gradient centrifugation. The hMSCs-enriched low-density fraction was collected, rinsed with DMEM, and plated in T25 flasks at 5 × 10 7 nucleated cells per flask in 5 ml regular growth medium consisting of low-glucose Dulbecco's modified Eagle's medium (DMEM; Gibco) supplemented with 10% fetal bovine serum (FBS; HyClone, Logan, UT), 4 mM L-glutamine, 100 U/ml penicillin, and 100 μg/ml streptomycin (Sigma-Aldrich). During the first two-week incubation for cell adherence and initial expansion, 5 ml of fresh growth medium was added twice weekly for the first week. And then, medium changes were carried out twice weekly. When adherent cells reached ~60% to 70% confluence, they were detached with 0.25% trypsin-EDTA (ethylenediamineteraacetic acid; Gibco) and replated at 1:3 in regular growth medium to allow for continued passaging. The experiments described here were performed after the fourth passage. 3T3-L1 cells, a mouse embryonic cell line with differentiation activity to adipocyte, were obtained from American Type Culture Collection (ATCC, Rockville, MD) and cultured in regular growth medium consisting of high-glucose DMEM (Gibco) supplemented with 10% FBS, 100 U/ml penicillin, and 100 μg/ml streptomycin. All cultures were kept in atmosphere of 5% CO 2 , 95% air at 37°C.
Determination of cellular FITC-MSN uptake by flow cytometry
hMSCs and 3T3-L1 cells were seeded at 1 × 10 5 cells per well in six-well plates and allowed to attach for 24 h. To determine the FITC-MSN uptake and loading contents, the cells were incubated with different concentrations of FITC-MSN suspension in serum-free medium for various incubation times. Treated cells were then washed three times with phosphate-buffered saline (PBS: 137 mM NaCl, 2.68 mM KCl, 10 mM Na 2 HPO 4 , 1.76 mM KH 2 PO 4 , pH 7.4), and then harvested by trypsinization. In some experiments, FITC-MSN-treated cells were allowed to grow in regular growth medium for 24 h for several days before trypsinization. After centrifuge, the cell pellet was washed once and resuspended with PBS containing 2% FBS. The fluorescent dye incorporated in FITC-MSN serves as a marker to quantitatively determine their cellular uptake analyzed by FACSCalibur flow cytometry and CellQuest Pro software (Becton Dickenson, Mississauga, CA) and also to study their intracellular distribution by confocal or fluorescence microscope. To study the mechanism of FITC-MSN uptake, cells were preincubated first with various inhibitors (Sigma-Aldrich) for the indicated time, as described below and then incubated with a suspension of FITC-MSNs (40 μg/ml) for another 30 min, which contained the respective inhibitors at the same concentration as that used for preincubation: 1) 0.1% w/v sodium azide and 50 mM 6-deoxyglucose for 1 h, 2) 450 mM sucrose for 1 h, 3) 30 μM cytochalasin D for 30 min, 4) 30 μM nocodazole for 30 min, 5) 3 μM phenylarsine oxide (PAO) for 30 min, and 6) 3 μg/ml filipin for 30 min. The effects of inhibitors on cellular FITC-MSN uptake were examined by flow cytometry, as described above.
Determination of cellular FITC-MSN uptake by microscopic studies
For confocal microscopy, cells were plated 24 h before the experiment in chamber slides at 5 × 10 3 cell/cm 2 . After incubation with FITC-MSNs, cells were washed three times with PBS and then fixed in a 4% formaldehyde solution in PBS at room temperature for 10 min. The cells were then washed twice with PBS and incubated with 0.1% Triton X-100 (Sigma-Aldrich) plus 1% bovine serum albumin (BSA; Sigma-Aldrich) in PBS at room temperature for 15 min followed by 5 μg/ml 4',6-diamidino-2-phenylindole (DAPI; Molecular Probes) staining in PBS for 3 min at room temperature. The slides were washed twice with PBS and then examined by a Leica TCS SP2 confocal spectral microscope using a ×63 oil immersion objective. For TEM, hMSCs and 3T3-L1 cells were plated 24 h before the experiment in 100-mm culture dishes at 1 × 10 6 cells per dish in 10 ml of growth medium. After incubation with FITC-MSNs for 1 h, cells were washed twice with PBS and then harvested by trypsinization. The harvested cells were fixed in a 2.5% glutaraldehyde solution in PBS and then postfixed in 1% osmium tetroxide in PBS for 1 h. The cells were washed twice with PBS containing 5% sucrose and dehydrated in a graded series of ethanol solutions (50%, 70%, 80%, 90%, 95%, and 100%); they were then soaked in a 1:1 ratio of 100% acetone and Spurr embedding resin (Electron Microscope Science) for 1 h, after which they were soaked in fresh Spurr resin for 3 h. The cells soaked in Spurr resin were then placed at 70°C for 24 h for polymerization of resin. The polymerized blocks were sectioned and then visualized under a Hitachi H-7100 microscope.
In vitro cytotoxicity and cell proliferation assay hMSCs and 3T3-L1 cells were seeded at 2 × 10 4 cells per well in 24-well plates and allowed to attach for 24 h. After incubation with different concentrations of FITC-MSN suspension in serum-free medium for 1 h, the cells were immediately washed with PBS and then incubated with fresh serum-free medium containing Cell Counting Kit-8 (CCK-8; DOJINDO Lab., Japan) reagent (WST-8, 2-(2-methoxy-4-nitrophenyl)-3-(4-nitro-phenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium), for 1 h at 37°C for cytotoxicity assay. For proliferation assay, FITC-MSN-treated cells were allowed to grow in regular growth medium for the indicated time and then incubated with CCK-8 reagent, as described in cytotoxicity assay. After incubation with CCK-8, the formazan dye generated by the activity of dehydrogenases in cells was proportional to the number of living cells and the absorbance at 450 nm was measured using a microplate reader (SpectraMAX M2; Molecular Devices, Sunnyvale, California) with a reference at 600 nm. Cell numbers were determined from a standard plot of known cell numbers vs. the corresponding absorbance density.
Immunophenotyping of hMSCs
hMSCs were seeded at 1 × 10 5 cells per well in 6-well plates and allowed to attach for 24 h. After incubation with FITC-MSNs for 1 h, cells were washed twice with PBS and then allowed to grow in regular growth medium for 5 days before being harvested. The harvested cells were stained with phycoerythrin (PE)-conjugated antibodies (Becton Dickinson) against human antigens CD10, CD13, CD14, CD29, CD34, CD44, CD90/Thy-1, CD117/c-kit, CD166, AC133, HLA-ABC, HLA-DR, and glycophorin A and analyzed by a Becton Dickinson FACSCalibur flow cytometry system.
In vitro differentiation studies
To induce adipogenic differentiation, hMSCs, and 3T3-L1 cells were first incubated with the indicated concentrations of FITC-MSNs for 1 h followed by PBS, washed, and then cultured in adipogenic medium or regular growth medium as control for 10 days and 7 days, respectively. Medium changes were carried out twice weekly. Adipogenic medium consists of high-glucose DMEM supplemented with 0.5 mM isobutyl-1-methylxanthine (IBMX; Sigma-Aldrich), 1 μM dexamethasone (Sigma-Aldrich), 10 ng/ml insulin (Sigma-Aldrich), 50 μM indomethacin (Sigma-Aldrich), and 10% FBS. To induce osteogenic differentiation, hMSCs were incubated first with the indicated concentrations of FITC-MSNs for 1 h followed by PBS, washed, and then treated with osteogenic medium for 4 wk, changing the medium twice weekly. Osteogenic medium consists of α-MEM (Gibco) supplemented with 1 μM dexamethasone, 50 μM β-glycerolphosphate (Sigma-Aldrich), and 50 μg/ml ascorbic acid (AsA; Sigma-Aldrich). To induce chondrogenic differentiation, hMSCs were incubated with the indicated concentrations of FITC-MSNs for 1 h followed by PBS wash. Then cells were transferred into 15-ml polypropylene tube and centrifuged at 1000 rpm for 5 min to form a pelleted micromass at the bottom of the tube. The cells were then treated with chondrogenic medium for 4 wk with medium changes twice weekly. Chondrogenic medium consists of low-glucose DMEM supplemented with 1 mM sodium pyruvate (Sigma-Aldrich), 0.1 μM dexamethasone, 0.1 mM AsA, 10 ng/ml transforming growth factor β (TGF-β1; R&D Systems, Minneapolis, MN), and 1 × ITS premix (Sigma-Aldrich; 5 μg/ml insulin, 5 μg/ml transferrin, and 25 ng/ml selenius acid).
Cytochemical analysis
Adipogenic differentiation was assessed by the cellular accumulation of neutral lipid vacuoles after cells were fixed with 4% formaldehyde, stained with oil-red O (Sigma-Aldrich). For evaluation of osteogenic differentiation, cells were fixed with 4% formaldehyde and stained with 1% Alizarin-red S (Sigma-Aldrich). Chondrogenic differentiation was evaluated after pellets were transferred into 96-well plates, fixed with 4% formaldehyde, and stained with 1% Alcian blue (Sigma-Aldrich).
Cellular distribution of FITC-MSNs
hMSCs were plated 24 h before the experiment in chamber slides or poly-L-lysine-coated glass cover slips at 5 × 10 3 cell/cm 2 . To study the intracellular distribution of FITC-MSNs, the cells were preincubated first with a suspension of FITC-MSNs for 30 min, and then incubated with 50 nM LysoTracker Red (Molecular Probes) or 1 μM nonyl acridine orange (NAO; Molecular Probes) in serum-free medium for another 30 min. After incubation, the cells were washed three times with PBS and visualized with serum-free medium. Images were acquired with a Zeiss Axiovert 100 M confocal unit.
Immunoblot analysis
Total cell lysate was lysed with lysis buffer containing 10 mM Tris (pH 7.0), 140 mM NaCl, 5 μg/ml protease inhibitor cocktail (Roche), and 1% Triton X−100. For Western blot analysis, proteins (30-60 µg) were separated by electrophoresis in a 6-15% polyacrylamide gel and transferred to a polyvinylidene difluoride membrane. After incubation at room temperature in PBS plus 1% bovine serum albumin for 1 h, the membrane was washed three times with PBS plus 0.1% Tween 20. Then the membrane was immunoreacted with mouse monoclonal IgG 2b clathrin light-chain antibody (Santa Cruz) overnight at 4°C. After four washes with PBS plus 0.1% Tween 20, horseradish peroxidase-conjugated anti-mouse or anti-rabbit IgG antibodies (diluted 1:2000) were applied to the membranes for 30 min at room temperature. Finally, the membranes were visualized with an enhanced chemiluminescence kit (Amersham Biosciences).
RESULTS
Cellular uptake of FITC-MSNs and their effect on cell viability and proliferation
Using flow cytometry, we determined cellular uptake of FITC-MSNs into hMSCs and 3T3-L1 cells quantitatively by the incorporated fluorescence intensity. The FITC-MSN uptake was time-(10 min, 30 min, and 1 h) and concentration-dependent (4, 13, and 40 μg/ml) in hMSCs, as well as in 3T3-L1 cells (Fig. 2) . The FITC-MSN uptake began efficiently as early as 10 min after incubation and was relatively rapid within the first 1-2 h of incubation (Fig. 2) , and a saturation uptake was achieved at 2 h and 2-4 h of incubation in hMSCs and 3T3-L1 cells, respectively (Fig.  3) . At higher doses of FITC-MSN treatment (130, 400 μg/ml), the histogram of fluorescence intensity exceeded the intensity scale, indicating a very efficient uptake of FITC-MSNs (Fig. 4A) . Moreover, the internalized FITC-MSNs stayed at least for 7 days in hMSCs but no more than 5 days in 3T3-L1 cells (Fig. 4B) at the same concentration of FITC-MSN treatment (40 μg/ml).
The confocal images showed that FITC-MSNs (green fluorescence) could be internalized into the cells and mainly resided in the cytoplasm (Fig. 5A) . Moreover, the TEM images showed that FITC-MSNs were indeed internalized into hMSCs and 3T3-L1 cells and still retained the architectural integrities, including highly ordered hexagonal pores, well-defined hexagonal edges, and particle size after their internalization into cells (Fig. 5B, arrow) .
To evaluate possible cytotoxic effect of FITC-MSNs, cell viability was examined by WST-8 reduction assay. No evidence of cytotoxicity was observed at 1 h after treatment with FITC-MSNs (Fig. 6A) , nor was the cell proliferation affected after FITC-MSN-treated cells were incubated with growth medium for the indicated times (Fig. 6B) . These data indicated that FITC-MSNs had high-efficiency internalizing abilities and were biocompatible.
Effects of FITC-MSNs on immunophenotypic characterization of hMSCs and cell differentiation activities
To exclude possible adverse effects of FITC-MSNs on the function of stem cells, we examined the immunophenotypes and differentiation potential of labeled cells. Immunophenotypic characterization of hMSCs by flow cytometry revealed that the cells isolated by the described method were positive for many markers common to hMSCs (23): CD13, CD29, CD44, CD90/Thy-1, CD166 (ALCAM), and HLA-ABC but negative for CD14, CD34, CD117, CD133 (AC133), HLA-DR, and glycophorin A. Identical profiles of immunophenotype were noted in labeled or control cells (Fig. 7) , suggesting that FITC-MSNs would not affect the potential for differentiation in hMSCs; nevertheless, the ability of labeled cells to differentiate into various phenotypes was also assessed.
Adipogenic differentiation with the formation and accumulation of lipid vacuoles could be observed after a 10-day and 7-day induction in hMSCs and 3T3-L1 cells, respectively ( Fig. 8B and  8E ). Adipogenic differentiation was not observed in cells grown in regular culture medium (hMSCs as shown in Fig. 8A ; 3T3-L1 as shown in Fig. 8D ). FITC-MSN-treated cells did differentiate into adipocytes (hMSCs as shown in Fig. 8C ; 3T3-L1 as shown in Fig. 8F ), and there was no obvious difference in oil-red O stain assay between untreated cells and FITC-MSN-treated cells (hMSCs as shown in Fig. 8B and C; 3T3-L1 as shown in Fig. 8E and F) . FITC-MSNs were observed in differentiated hMSCs (data not shown).
As compared with undifferentiated hMSCs (incubation with regular growth medium as negative control as shown in Fig. 9A ), mineralized matrix deposition by hMSCs could be observed as evidenced by Alizarin red staining after incubation with osteogenic medium (Fig. 9B) . No obvious difference in Alizarin red staining was observed from FITC-MSN-treated cells after osteogenic differentiation (Fig. 9C) . In addition, high-density micromass cultures of hMSCs incubated in chondrogenic medium condensed into small spheroids that were visible to the naked eye. The cartilaginous nodules were stained positively for Alcian blue and no apparent discrepancy was observed between untreated cells and FITC-MSN-treated cells ( Fig. 9D and E) . These data showed that FITC-MSNs would not affect the multipotent differentiation activities of hMSCs.
Mechanism of FITC-MSN uptake and intracellular distribution
Several inhibitors were used to explore the mechanism of FITC-MSN uptake. As shown in Fig. 10 , FITC-MSN uptake in hMSCs was energy-dependent because this process was blocked after energy depletion by a mixture of sodium azide and 6-deoxyglucose (Fig. 10A) . Inhibition of clathrin-coated pit endocytosis by sucrose-induced hypertonicity decreased FITC-MSN uptake, whereas inhibition of caveola-coated pit endocytosis by filipin did not affect FITC-MSN uptake. A clathrin inhibitor, PAO, also decreased FITC-MSN uptake (Fig. 10B) . These evidences suggested that clathrin but not caveolae was involved in FITC-MSN uptake.
Furthermore, we examined the correlation between clathrin protein expression and FITC-MSN uptake in 3T3-L1 cells and hMSCs. Interestingly, 3T3-L1 cells displayed less FITC-MSN uptake,
Page 7 of 24 (page number not for citation purposes)
as well as reduced clathrin protein expression than hMSCs (Fig. 10C) , and this finding also indicated that clathrin-mediated endocytosis contributed to the FITC-MSN uptake. In addition, FITC-MSN uptake was not inhibited by nocodazole, a microtubule inhibitor, which suggested that microtubules did not play a role in the uptake of FITC-MSNs (Fig. 10D) . However, the fact that inhibition of actin polymerization by cytochalasin D decreased FITC-MSN uptake implied that microfilaments might be involved in controlling intracellular FITC-MSN uptake (Fig. 10D) . Similar effects of these inhibitors also could be observed on 3T3-L1 cells (data not shown).
Because in the endocytic pathway, ingested molecules are delivered to early endosomes and then (via late endosomes) to lysosomes, we studied the colocalization of LysoTracker Red, a marker for late endosomes and lysosomes with red fluorescence, with FITC-MSNs (green fluorescence). A partial colocalization (orange to yellow fluorescence) in the cytoplasmic compartment was exhibited (Fig. 11A) . However, FITC-MSNs appeared to accumulate in compartments separated from the LysoTrack-labeled compartments, which suggested that FITC-MSNs might be stored in different compartments in the cytoplasm. As shown in Fig. 11B , some internalized FITC-MSNs were colocalized with NAO (a mitochondria-selective probe) in the mitochondria, as evident from the appearance of yellow fluorescence.
DISCUSSION
A major problem inherent in the study of stem cell use in tissue regeneration is the difficulty in tracking the movement of implanted cells. Recent studies reveal that superparamagnetic iron oxide nanoparticles that consist of an inorganic core of iron oxide coated with various polymer substances are ideally suited for tracking stem cells via intracellular magnetic labeling (internalization). Unfortunately, the internalizing efficiency is generally low despite various substitutes of the coating materials. Internalized labeling of the cultured stem cells with superparamagnetic iron oxide nanoparticles covered by polystyrene, dendrimer, and dextran (Endorem) requires long-term incubation, from 10 hours or so to a few days in previous studies (9, 10, 12, 13) . In this superparamagnetic iron oxide system, the coating substance serves a vector and determines the internalizing efficiency of the whole nanoparticle.
An alternative strategy to improve the internalizing efficiency is to modify the surface of vector. Although this approach, as in the example of attaching HIV-1 tat peptides with particle vector (8) , efficiently enhanced the internalization of the particles into hematopoietic and neural progenitor cells and did not affect cell viability, differentiation, or proliferation of CD34 + cells, the modification of peptide attachment would reduce the convenience of practicality. Moreover, the possible adverse effects of the attached peptide on cells still remain to be explored.
In this study, we successfully labeled hMSCs and 3T3-L1 cells with new nanoparticle vectors built of silica with fluorescein isothiocyanate, termed FITC-MSNs. Without any modification, FITC-MSNs could be internalized into cells efficiently as evidenced by a swift occurrence of uptake detected by flow cytometry in a concentration-and time-dependent manner. The FITC-MSN internalization occurred within the 10-min treatment and substantially accumulated during the first 2-h incubation. Microscopic examinations demonstrated that the intracellular internalization detected by flow cytometry was not due to the adherence to cell surface. As compared with 3T3-L1 cells, hMSCs internalized FITC-MSNs more efficiently and reserved the intracellular FITC-MSNs longer, and this finding implies that FITC-MSNs could be an appropriate candidate for the use of stem cell tracking. We also demonstrated that FITC-MSN
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internalization did not affect cell viability, cell proliferation, and the immunophenotypic profiles of surface markers in hMSCs. Furthermore, the labeled 3T3-L1 cells exerted equal adipogenic differentiation ability to the untreated cells after cellular internalization of FITC-MSNs, and the labeled hMSCs also retained their multipotency to differentiate into fat (adipocytes), cartilage (chondrocytes), and bone (osteocytes). These facts indicated that FITC-MSNs are quite biocompatible.
Although several reports have demonstrated that a FITC-doped silica nanoparticle material could be used for labeling various types of cells, the cellular internalization of nanoparticles (24) and the cell recognition by dye-doped particles (25, 26) were based on nanoparticle surface-conjugation with PTDs and specific antibodies, respectively. In addition, the mesoporous silica nanoparticles used for intracellular drug/gene delivery have also been reported, but the particles played an assistant role in enhancing gene transfection efficiency or the cellular internalizing efficiency of nanoparticles was neglected (27) (28) (29) . To the best of our knowledge, no study has reported before on the high internalizing efficiency and biocompatibility of native mesoporous silica nanoparticles in human mesenchymal stem cells.
Endocytosis is the main mechanism of cellular internalization for the magnetic nanoparticle vectors and tat peptide-derivative nanoparticles (14) (15) (16) (30) (31) (32) . In our study, FITC-MSNs were internalized in an energy-dependent manner, which suggested the role of endocytosis in the process (33) . This speculation was further supported by the fact that FITC-MSNs could be found in the late endosomes or lysosomes after internalization. Moreover, FITC-MSN uptake was significantly reduced after the inhibition of clathrin but not caveolae, which indicated the involvement of clathrin-dependent endocytosis in the uptake pathway. However, our FITC-MSNs did not possess any specific ligands for receptor-mediated intracellular uptake. We thus assumed that FITC-MSN internalization nonspecifically took advantage of the inherently formed clathrin-coated vesicles. The fact that the clathrin protein expression was positively correlated with the amount of FITC-MSN uptake supports the possibility that FITC-MSNs were being internalized by a nonspecific mechanism. Alternatively, the nonspecific but highly efficient internalization of FITC-MSNs partially originated in the strong affinity to clathrin-coated vesicles caused by their characteristics, that is, the siliceous ingredients and the unique architecture of hexagonal exterior with hexagonal mesopores inside. A long-term incubation is thus necessary for adequate internalization of the native magnetic nanoparticle vectors composed of nonsiliceous substances, but not in the case of FITC-MSNs. These two classes of nanoparticles should be compared in an identical cell system to clarify their variations in cellular internalization. In our study, phagocytosis appeared to substantially contribute to the FITC-MSN internalization as confirmed by the inhibitory effect on the FITC-MSN intracellular uptake after the inhibition of microfilament polymerization.
Most endocytic contents are delivered to lysosomes for degradation unless there are special mechanisms for the contents to escape from the endolysosomes (34) . However, after their internalization, FITC-MSNs retained the architectonic integrity and appeared to escape from endolysosomal vesicles. Two possible mechanisms for the endolysosomal escape of viral and nonviral vectors used in gene therapy are generally believed. For viral vectors, a fusogen peptide could be used to cross the endosomal membrane. For nonviral vectors, one is that the DNA-cationic compound could fuse with the endolysosomal membranes, leading to the endolysosomal escape; another possibility is that the cationic lipids and polymers cause the swelling and rupture of the lysosomes by sequestering protons and their counterions (the "proton sponge effect") and create an osmotic imbalance similar to that created by lysosomotropic compounds, which would result in cytotoxicity (35) . FITC-MSN exhibited a negative zeta potential (ζ) value of -5 mV and +45 mV at pH 7 and pH 5, respectively. The surface cationization forming a condition of pH 7 to another one of pH 5 could explain the lysosomal escape of FITC-MSNs. The early endocytic vesicles have a physiological pH (33) at which FITC-MSNs would have a net negative charge and hence would be repelled by the negatively charged endosomal membrane. However, the late endosomes and lysosomes are predominantly acidic, with pH values ranging from 4 to 5 (33) . In this pH, FITC-MSNs would have a net cationic potential (+45 mV) and hence would interact with the negatively charged membrane, leading to the escape of FITC-MSNs into the cytoplasmic compartment. Because we did not observe any cytotoxicity with FITC-MSNs, it is suggested that FITC-MSNs escape from endolysosomal vesicles via the localized destabilization of endolysosomal membrane but not via the rupture of endolysosomal vesicles with surface cationization. These two additional characteristics of FITC-MSNs, the durability and the endolysomal escape, reinforce their other potential application, especially in drug delivery (34) .
In conclusion, our data demonstrate that 1) the mesoporous silica nanoparticles can be internalized efficiently into hMSCs and 3T3-L1 cells by clathrin-dependent endocytosis; 2) the mesoporous silica nanoparticles are nontoxic without affecting cell viability, growth, and differentiation; 3) human mesenchymal stem cells can internalize more mesoporous silica nanoparticles and keep them inside longer; 4) the mesoporous silica nanoparticles can escape from endolysosomal vesicles and resist lysosomal degradation. Although further investigations are warranted to evaluate the potential use of mesoporous silica nanoparticles, these results at least suggest the potential application of these nanoparticles in stem cell tracking. 
